AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,279,684 | +1715.0% | 187,474 | +1774.7% | 0.01% | – |
| Q2 2023 | $125,600 | +12.1% | 10,000 | -1.0% | 0.00% | – |
| Q1 2023 | $112,009 | -72.4% | 10,100 | -69.7% | 0.00% | -100.0% |
| Q4 2022 | $406,373 | +22.0% | 33,282 | +4.2% | 0.00% | – |
| Q3 2022 | $333,000 | -34.2% | 31,935 | -32.2% | 0.00% | -100.0% |
| Q2 2022 | $506,000 | -37.2% | 47,100 | -44.7% | 0.00% | -33.3% |
| Q1 2022 | $806,000 | +70.0% | 85,100 | +107.1% | 0.00% | +200.0% |
| Q4 2021 | $474,000 | -71.0% | 41,100 | -76.0% | 0.00% | -83.3% |
| Q3 2021 | $1,635,000 | -1.9% | 171,200 | -1.0% | 0.01% | -14.3% |
| Q2 2021 | $1,667,000 | -36.5% | 172,900 | -34.9% | 0.01% | -41.7% |
| Q1 2021 | $2,624,000 | +272.7% | 265,596 | +770.8% | 0.01% | +200.0% |
| Q4 2020 | $704,000 | +245.1% | 30,500 | +111.6% | 0.00% | +300.0% |
| Q3 2020 | $204,000 | -56.5% | 14,413 | -53.6% | 0.00% | -66.7% |
| Q2 2020 | $469,000 | +300.9% | 31,054 | +144.5% | 0.00% | +200.0% |
| Q1 2020 | $117,000 | -3.3% | 12,700 | +1.6% | 0.00% | – |
| Q4 2019 | $121,000 | -53.5% | 12,500 | -34.8% | 0.00% | -100.0% |
| Q1 2019 | $260,000 | -85.5% | 19,186 | -89.8% | 0.00% | -84.6% |
| Q4 2018 | $1,797,000 | +46.2% | 187,500 | +84.5% | 0.01% | +116.7% |
| Q3 2018 | $1,229,000 | -45.8% | 101,600 | -30.0% | 0.01% | -50.0% |
| Q2 2018 | $2,268,000 | – | 145,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |